Similar articles for PMID: 20932672

Year	Number of Results
1998	1
1999	1
2000	1
2001	1
2002	1
2003	1
2004	3
2005	5
2006	3
2007	3
2008	3
2009	6
2010	14
2011	12
2012	13
2013	4
2014	3
2015	6
2016	4
2017	5
2018	6
2019	7
2020	10
2021	8
2022	8
2023	1
2024	0

1

Parameters favorable to intraprostatic radiation dose escalation in men with localized prostate cancer.

Housri N, Ning H, Ondos J, Choyke P, Camphausen K, Citrin D, Arora B, Shankavaram U, Kaushal A. Housri N, et al. Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):614-20. doi: 10.1016/j.ijrobp.2010.06.050. Epub 2010 Oct 6. Int J Radiat Oncol Biol Phys. 2011. PMID: 20932672 Free PMC article. Clinical Trial.

2

Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT.

Kuang Y, Wu L, Hirata E, Miyazaki K, Sato M, Kwee SA. Kuang Y, et al. Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):1017-25. doi: 10.1016/j.ijrobp.2014.12.052. Int J Radiat Oncol Biol Phys. 2015. PMID: 25832692 Free PMC article.

3

Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study.

Ost P, Speleers B, De Meerleer G, De Neve W, Fonteyne V, Villeirs G, De Gersem W. Ost P, et al. Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):920-6. doi: 10.1016/j.ijrobp.2010.04.025. Epub 2010 Aug 2. Int J Radiat Oncol Biol Phys. 2011. PMID: 20675077

4

Prostate stereotactic ablative radiation therapy using volumetric modulated arc therapy to dominant intraprostatic lesions.

Murray LJ, Lilley J, Thompson CM, Cosgrove V, Mason J, Sykes J, Franks K, Sebag-Montefiore D, Henry AM. Murray LJ, et al. Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):406-15. doi: 10.1016/j.ijrobp.2014.01.042. Epub 2014 Mar 28. Int J Radiat Oncol Biol Phys. 2014. PMID: 24685447 Free PMC article.

5

Dominant intraprostatic lesion boosting in sexual-sparing radiotherapy of prostate cancer: A planning feasibility study.

Ciabatti S, Ntreta M, Buwenge M, Gaudiano C, Sessagesimi E, Romani F, Angelini AL, Cammelli S, Macchia G, Deodato F, Zamagni A, Golfieri R, Morganti AG, Cilla S. Ciabatti S, et al. Med Dosim. 2019 Winter;44(4):356-364. doi: 10.1016/j.meddos.2019.01.008. Epub 2019 Apr 5. Med Dosim. 2019. PMID: 30955990

6

Highly hypofractionated intensity-modulated radiation therapy for nonmetastatic prostate cancer with a simultaneous integrated boost to intraprostatic lesions: a planning study.

Ashida R, Nakamura K, Aizawa R, Iramina H, Takayama K, Nakamura M, Mizowaki T. Ashida R, et al. Jpn J Radiol. 2022 Feb;40(2):210-218. doi: 10.1007/s11604-021-01186-6. Epub 2021 Aug 5. Jpn J Radiol. 2022. PMID: 34350542 Free article.

7

IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI.

van Lin EN, Fütterer JJ, Heijmink SW, van der Vight LP, Hoffmann AL, van Kollenburg P, Huisman HJ, Scheenen TW, Witjes JA, Leer JW, Barentsz JO, Visser AG. van Lin EN, et al. Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):291-303. doi: 10.1016/j.ijrobp.2005.12.046. Int J Radiat Oncol Biol Phys. 2006. PMID: 16618584

8

An atlas-based electron density mapping method for magnetic resonance imaging (MRI)-alone treatment planning and adaptive MRI-based prostate radiation therapy.

Dowling JA, Lambert J, Parker J, Salvado O, Fripp J, Capp A, Wratten C, Denham JW, Greer PB. Dowling JA, et al. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):e5-11. doi: 10.1016/j.ijrobp.2011.11.056. Epub 2012 Feb 11. Int J Radiat Oncol Biol Phys. 2012. PMID: 22330995

9

Simultaneous integrated boost with stereotactic radiotherapy for dominant intraprostatic lesion of localized prostate cancer: a dosimetric planning study.

Kim YJ, Yoon KJ, Kim YS. Kim YJ, et al. Sci Rep. 2020 Sep 7;10(1):14713. doi: 10.1038/s41598-020-71715-2. Sci Rep. 2020. PMID: 32895442 Free PMC article.

10

Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer.

Tamihardja J, Cirsi S, Kessler P, Razinskas G, Exner F, Richter A, Polat B, Flentje M. Tamihardja J, et al. Radiat Oncol. 2021 Oct 26;16(1):205. doi: 10.1186/s13014-021-01933-z. Radiat Oncol. 2021. PMID: 34702305 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

105 results

Results by year